What sector does Amrutajan Health Ltd belong to?

Amrutajan Health Ltd operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of AMRUTANJAN?

As of the latest available quote, AMRUTANJAN traded at ₹490.95. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of AMRUTANJAN?

Amrutajan Health Ltd has a price-to-earnings (P/E) ratio of about 26.31. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of AMRUTANJAN?

The market capitalisation of Amrutajan Health Ltd is approximately ₹1,419 Cr.

Is Amrutajan Health Ltd profitable?

For its latest reported financial year, Amrutajan Health Ltd recorded a net profit margin of about 11.86%.

Does AMRUTANJAN pay a dividend?

Amrutajan Health Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of AMRUTANJAN?

Amrutajan Health Ltd has a return on equity (ROE) of about 20.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of AMRUTANJAN?

Over the past 52 weeks, AMRUTANJAN has traded between a low of ₹482.80 and a high of ₹774.30.

Amrutajan Health Ltd

AMRUTANJAN NSE Healthcare Pharmaceuticals

₹490.95

-0.47%

Delayed · cached 15 min

Fair value analysis

AMRUTANJAN

Amrutajan Health Ltd

₹493.25

Close used for this calculation

₹198.14Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

55/100

Profitability21/25

Returns8/25

Balance Sheet21/25

Efficiency5/25

Growth15/25

Good

Quality radar

Consensus fair value

₹198.14

Above FV

▼ -59.8% against the close used

Model range ₹77.02 – ₹317.50

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹77.02Fair value₹198.14Bull₹317.50

FairClose

52-week traded range

52W low ₹488.2552W high ₹765.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Amrutajan Health Ltd closed at ₹493.25, 148.9% above the consensus fair value of ₹198.14 drawn from 10 valuation models.

Financial DNA score 55/100 — Good. P/E of 69.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹131.09

-73.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹77.02

-84.4%

√(22.5 × EPS × BVPS)

EPS=7.05, BVPS=37.4 · outside Graham range (P/E 69.6, P/B 13.2) — asset-light, treat as a rough floor

Graham Formula

₹317.50

-35.6%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹251.69

-49.0%

EPS × 35.7x (sector P/E)

EPS=7.05, Sector P/E=35.7x

Peter Lynch (PEG)

₹176.25

-64.3%

EPS × Growth% (PEG = 1 is fair)

EPS=7.05, g=25%

EV/EBITDA

₹212.04

-57.0%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=340M

Dividend Discount (DDM)

₹266.35

-46.0%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=4.93, r=10%, g=8%

Book Value (P/B)

₹130.89

-73.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=37.4, ROE=20%, g=6%, r=10%

Reverse DCF

₹493.25

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 24.1% | Historical: 25%

Margin of Safety

₹145.74

-70.5%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=194.33, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer